---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-054784"
form_type: "8-K"
ticker: "ORIC"
cik: "0001796280"
company_name: "Oric Pharmaceuticals, Inc."
filed_at: "2025-03-14T23:59:59+00:00"
generated_at: "2026-05-24T18:44:51.808509+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# ORIC Pharmaceuticals amends inducement equity plan, adds 1.1M shares to reserve

## Summary
- Compensation Committee approved Amended and Restated 2022 Inducement Plan, adding 1,100,000 shares to reserve.
- Total shares reserved under the plan increased to 2,250,000 shares.
- Amendment adopted without stockholder approval under Nasdaq Listing Rules.
- Awards are inducement material for new employees and non-employee directors under Nasdaq Rule 5635(c)(4).

## SEC filing metadata
- accession: 0001193125-25-054784
- form_type: 8-K
- ticker: ORIC
- cik: 0001796280
- company_name: Oric Pharmaceuticals, Inc.
- filed_at: 2025-03-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1796280/000119312525054784/0001193125-25-054784-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1796280/000119312525054784/d873253d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-054784
- JSON: https://secwatch.observer/filing/0001193125-25-054784.json
- Plain text: https://secwatch.observer/filing/0001193125-25-054784.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.